logo

Sonoma Pharmaceuticals Inc. (SNOA) Stock: A Year of Highs and Lows in the Market

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Sonoma Pharmaceuticals Inc.’s current trading price is -89.61% away from its 52-week high, while its distance from the 52-week low is 36.32%. The stock’s price range for this period has been between $0.12 and $1.52 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.32 million for the day, a number notably higher than the average daily volume of 1.89 million over the last three months.

Sonoma Pharmaceuticals Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $1.52 on 06/09/23, while the lowest price for the same period was registered at $0.12 on 11/10/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Sonoma Pharmaceuticals Inc. (SNOA) has experienced a quarterly decline of -7.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.47M and boasts a workforce of 171 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1657, with a change in price of -0.0050. Similarly, Sonoma Pharmaceuticals Inc. recorded 1,740,427 in trading volume during the last 100 days, posting a change of -3.07%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SNOA stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.02.

SNOA Stock Stochastic Average

Sonoma Pharmaceuticals Inc.’s raw stochastic average for the past 50 days is presently 14.41%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 69.33%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 41.60% and 27.04%, respectively.

SNOA Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -12.42% this year. Over the last six months, there has been a stronger performance of -79.48%. The price of SNOA fallen by 5.33% during the last 30 days period. For the last 5-days stocks have improved 8.97%.